CDXS Company Profile and Key Details

Q: Who are the executives of CDXS?

Mr. Ross Taylor Jr., M.B.A.Senior Vice President & Chief Financial OfficerMr. John J. NicolsDirector & Strategic AdvisorMr. Kevin Norrett M.B.A., M.S.Chief Operating OfficerMs. Margaret Fitzgerald J.D.Chief Legal and Compliance Officer, Gen. Counsel & Sec.Dr. Stephen George Dilly MBBS, Ph.D.Pres, Chief Executive Officer & DirectorMs. Asli Aras Ph.D.Vice President & Head of Corporation Devel.Ms. Karen Frechou-ArmijoSenior Vice President & Head of HRDr. Stefan Lutz Ph.D.Senior Vice President of ResearchMr. Robert Sato M.B.A., Ph.D.Senior Vice President of Pharmaceutical Devel., Quality & RegulatoryMr. Rob Wilson Ph.D.Senior Vice President & GM of Performance EnzymesCarrie McKimDirector of Investor RelationsDr. Karl A. Schoene Ph.D.Senior Vice President of Devel. & Operations

NASDAQ : CDXS

Codexis

$1.17

-0.01-0.85%

At Close 4:00 PM

57.87

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Codexis, Inc. (CDXS) stock declined over -0.85%, trading at $1.17 on NASDAQ, down from the previous close of $1.18. The stock opened at $1.18, fluctuating between $1.14 and $1.19 in the recent session.

Stock Snapshot

1.18

Prev. Close

105.68M

Market Cap

1.14

Day Low

-1.6

P/E Ratio

-0.73

EPS (TTM)

-0.82

Cash Flow per Share

1.18

Open

90.32M

Number of Shares

1.19

Day High

108.98%

Free Float in %

1.25

Book Value

1.75M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 20, 2026	1.17	1.19	1.14	1.17	1.75M
Feb 19, 2026	1.17	1.21	1.15	1.18	708.86K
Feb 18, 2026	1.19	1.22	1.14	1.17	1.06M
Feb 17, 2026	1.20	1.23	1.16	1.21	926.93K
Feb 13, 2026	1.19	1.28	1.19	1.20	1.38M
Feb 12, 2026	1.20	1.22	1.12	1.18	1.49M
Feb 11, 2026	1.26	1.27	1.16	1.19	1.55M
Feb 10, 2026	1.29	1.33	1.24	1.25	857.42K
Feb 09, 2026	1.33	1.35	1.28	1.29	690.98K
Feb 06, 2026	1.30	1.36	1.27	1.33	1.2M
Feb 05, 2026	1.30	1.34	1.24	1.27	1.66M
Feb 04, 2026	1.37	1.39	1.28	1.32	1.54M
Feb 03, 2026	1.42	1.48	1.31	1.36	982.15K
Feb 02, 2026	1.26	1.46	1.25	1.44	1.72M
Jan 30, 2026	1.30	1.30	1.22	1.24	1.08M
Jan 29, 2026	1.30	1.34	1.25	1.30	1.6M
Jan 28, 2026	1.46	1.48	1.28	1.29	1.7M
Jan 27, 2026	1.54	1.55	1.32	1.43	2.67M
Jan 26, 2026	1.69	1.71	1.54	1.55	1.28M
Jan 23, 2026	1.82	1.89	1.66	1.68	1.22M

Contact Details

Redwood City, CA 94063

United States

https://www.codexis.com 650 421 8100

About Company

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Stock Peers

ARGX

-2.85-0.34%

argenx SE$844.41 REGN

-1.77-0.23%

Regeneron Pharmaceuticals, Inc.$779.67 VRTX

7.63+1.63%

Vertex Pharmaceuticals Incorporated$476.90 UTHR

-7.1-1.48%

United Therapeutics Corporation$473.42 MDGL

-1.86-0.43%

Madrigal Pharmaceuticals, Inc.$435.01 ALNY

-3.18-0.94%

Alnylam Pharmaceuticals, Inc.$336.19 PRAX

3.67+1.11%

Praxis Precision Medicines, Inc.$335.28 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-0.87-0.33%

Krystal Biotech, Inc.$261.80 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Codexis, Inc. (CDXS) stock price?

Codexis, Inc. (NASDAQ: CDXS) stock price is $1.17 in the last trading session. During the trading session, CDXS stock reached the peak price of $1.19 while $1.14 was the lowest point it dropped to. The percentage change in CDXS stock occurred in the recent session was -0.85% while the dollar amount for the price change in CDXS stock was - $0.01.

CDXS's industry and sector of operation?

The NASDAQ listed CDXS is part of Biotechnology industry that operates in the broader Healthcare sector. Codexis, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CDXS?

Mr. Ross Taylor Jr., M.B.A.
Senior Vice President & Chief Financial Officer
Mr. John J. Nicols
Director & Strategic Advisor
Mr. Kevin Norrett M.B.A., M.S.
Chief Operating Officer
Ms. Margaret Fitzgerald J.D.
Chief Legal and Compliance Officer, Gen. Counsel & Sec.
Dr. Stephen George Dilly MBBS, Ph.D.
Pres, Chief Executive Officer & Director
Ms. Asli Aras Ph.D.
Vice President & Head of Corporation Devel.
Ms. Karen Frechou-Armijo
Senior Vice President & Head of HR
Dr. Stefan Lutz Ph.D.
Senior Vice President of Research
Mr. Robert Sato M.B.A., Ph.D.
Senior Vice President of Pharmaceutical Devel., Quality & Regulatory
Mr. Rob Wilson Ph.D.
Senior Vice President & GM of Performance Enzymes
Carrie McKim
Director of Investor Relations
Dr. Karl A. Schoene Ph.D.
Senior Vice President of Devel. & Operations

How CDXS did perform over past 52-week?

CDXS's closing price is 4.46% higher than its 52-week low of $1.12 where as its distance from 52-week high of $4.46 is -73.77%.

How many employees does CDXS have?

Number of CDXS employees currently stands at 188.

Link for CDXS official website?

Official Website of CDXS is: https://www.codexis.com

How do I contact CDXS?

CDXS could be contacted at phone 650 421 8100 and can also be accessed through its website. CDXS operates from 200 Penobscot Drive, Redwood City, CA 94063, United States.

How many shares of CDXS are traded daily?

CDXS stock volume for the day was 1.75M shares. The average number of CDXS shares traded daily for last 3 months was 1.05M.

What is the market cap of CDXS currently?

The market value of CDXS currently stands at $105.68M with its latest stock price at $1.17 and 90.32M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	188
Beta	2.47
Sales or Revenue	$70.14M
5Y Sales Change%	-0.113%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	188
Beta	2.47
Sales or Revenue	$70.14M
5Y Sales Change%	-0.113%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CDXS Company Profile and Key Details

Codexis

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics